Javascript is required for this site to function correctly.
Please enable Javascript support.

Snapshots of MJFF Recently Awarded Grants

The Foundation supports research that will lead to the creation of better Parkinson's treatments. Here are some of the patient-relevant projects the Foundation has recently funded.

If you are looking for a specific project, please search our Funded Grants Database.

Enhanced Activity in Pre-clinical Models of Parkinsonism and Levodopa-induced Dyskinesia by Preferential Targeting of Sub-populations of 5-HT1A Receptors

Adrian Newman-Tancredi, PhD
Institution: Neurolixis, Inc.
MJFF Program: Target Validation 2012
Delivery of GDNF to the Brain by Novel Nanovesicles for the Treatment of PD

Eliahu Heldman, PhD
Institution: Lauren Sciences, LLC
MJFF Program: Therapeutics Development Initiative 2011
Sarina Grinberg, PhD
Institution: Ben-Gurion University of the Negev
MJFF Program: Therapeutics Development Initiative 2011
Charles Linder, PhD
Institution: Ben-Gurion University of the Negev
MJFF Program: Therapeutics Development Initiative 2011
Irwin Hollander, PhD
Institution: Lauren Sciences, LLC
MJFF Program: Therapeutics Development Initiative 2011
Dopamine D1 Positive Modulators for the Treatment of Parkinson's Disease

Isabel Gonzalez PhD, BSc, MSc
Institution: Proximagen Ltd.
MJFF Program: Therapeutics Development Initiative 2011
Kim Amelia Stockwell PhD, BSc
Institution: Proximagen Ltd.
MJFF Program: Therapeutics Development Initiative 2011
Pathway Validation of a Biased Delta Opioid Receptor Ligand for PD Symptomatic Relief

Michael W. Lark, PhD
Institution: Trevena, Inc.
MJFF Program: Target Validation 2011
Alpha-synuclein and Tau Mislocalization to Dendritic Spines

Dezhi Liao, PhD
Institution: The University of Minnesota
MJFF Program: Rapid Response Innovation Awards 2011
Next: Searchable Database of MJFF Awarded Grants
Print This Page Email This Page